IL17A and cancer: For example, FUOM was strongly implicated in Th17 cell differentiation, a pathway known to drive tumor‐promoting inflammation, while H2BC21 was associated with TNF and IL‐17 signaling, which are integral to immune evasion and chronic inflammation in cancer [49, 50].